Table 1 Characteristics of the sample according to SARS-CoV-2 PCR status.
SARS-CoV-2 PCR status | p-value | |||
|---|---|---|---|---|
Subacute positive | Postcovid positive | Negative | ||
N = 1425 | N = 1584 | N = 7185 | ||
Weeks between PCR and survey*, median (IQR) | 8.4 (6.4–10.1) | 31.8 (14.4–37.4) | 23.0 (15.7–33.7) | N/A |
Number of tests, median (IQR) | 3.0 (2.0–4.0) | 2.0 (1.0–2.0) | 2.0 (1.0–3.0) | < 0.001† |
Age, mean (SD) | 44.4 (11.8) | 44.6 (12.4) | 45.0 (12.1) | 0.14‡ |
Female | 1248 (87.6%) | 1320 (83.3%) | 6181 (86.0%) | 0.003 |
Occupation | < 0.001 | |||
Manager | 62 (4.4%) | 86 (5.4%) | 461 (6.4%) | |
Health professional | 375 (26.3%) | 535 (33.8%) | 1906 (26.5%) | |
Other/associate professional | 242 (17.0%) | 222 (14.0%) | 1774 (24.7%) | |
Care worker | 678 (47.6%) | 650 (41.0%) | 2502 (34.8%) | |
Other occupation/unknown | 68 (4.8%) | 91 (5.7%) | 542 (7.5%) | |
Place of living | < 0.001 | |||
Gothenburg urban area | 805 (56.5%) | 991 (62.6%) | 3830 (53.3%) | |
Other urban area | 389 (27.3%) | 362 (22.9%) | 2142 (29.8%) | |
Rural | 228 (16.0%) | 213 (13.4%) | 1139 (15.9%) | |
Other part of Sweden/unknown | 3 (0.2%) | 18 (1.1%) | 74 (1.0%) | |
Exposure to COVID-19 patients at work | < 0.001 | |||
No/No patient contact | 585 (41.1%) | 671 (42.4%) | 4567 (63.6%) | |
Occasionally | 329 (23.1%) | 341 (21.5%) | 1412 (19.7%) | |
Several times | 361 (25.3%) | 383 (24.2%) | 808 (11.2%) | |
Worked exclusively with COVID-19 patients for some period | 150 (10.5%) | 189 (11.9%) | 398 (5.5%) | |
BMI, mean (SD) | 26.8 (5.1) | 26.4 (5.2) | 26.3 (5.1)** | 0.006‡ |
Nicotine use | ||||
No | 1091 (76.6%) | 1245 (78.6%) | 5442 (75.7%) | |
Smokeless tobacco | 178 (12.5%) | 206 (13.0%) | 825 (11.5%) | |
Smoker | 112 (7.9%) | 97 (6.1%) | 709 (9.9%) | |
Tobacco free nicotine product | 44 (3.1%) | 36 (2.3%) | 209 (2.9%) | |
Pre-existing medical conditions | ||||
Hypertension | 151 (10.6%) | 167 (10.5%) | 810 (11.3%) | 0.58 |
Other cardiovascular disease | 30 (2.1%) | 35 (2.2%) | 176 (2.4%) | 0.67 |
Diabetes mellitus type 1 | 7 (0.5%) | 19 (1.2%) | 79 (1.1%) | 0.089 |
Diabetes mellitus type 2 | 29 (2.0%) | 32 (2.0%) | 130 (1.8%) | 0.76 |
Asthma | 157 (11.0%) | 152 (9.6%) | 728 (10.1%) | 0.43 |
Allergy | 329 (23.1%) | 326 (20.6%) | 1551 (21.6%) | 0.24 |
Thyroid illness | 109 (7.6%) | 103 (6.5%) | 492 (6.8%) | 0.44 |
Other autoimmune disease | 88 (6.2%) | 96 (6.1%) | 502 (7.0%) | 0.27 |
Mental disorder | 225 (15.8%) | 181 (11.4%) | 1104 (15.4%) | < 0.001 |
Illness severity in adjunction to test | < 0.001 | |||
No symptoms | 116 (8.1%) | 67 (4.2%) | 977 (13.6%) | |
Mild symptoms | 507 (35.6%) | 544 (34.3%) | 4863 (67.7%) | |
Bedridden | 753 (52.8%) | 904 (57.1%) | 1288 (17.9%) | |
Needed to seek health care | 40 (2.8%) | 56 (3.5%) | 57 (0.8%) | |
Hospitalized | 9 (0.6%) | 13 (0.8%) | 0 (0.0%) | |
Vaccinated against COVID-19 | 233 (16.4%) | 375 (23.7%) | 1730 (24.1%) | < 0.001 |
Care seeking for surveyed complaints in the last month*** | < 0.001 | |||
Have complaints, but no care seeking | 691 (48.5%) | 723 (45.6%) | 2342 (32.6%) | |
Primary care center | 211 (14.8%) | 207 (13.1%) | 790 (11.0%) | |
Other outpatient (e.g. specialist, physiotherapist) | 55 (3.9%) | 79 (5.0%) | 364 (5.1%) | |
Emergency department | 36 (2.5%) | 21 (1.3%) | 66 (0.9%) | |
Hospitalized | 11 (0.8%) | 1 (0.1%) | 33 (0.5%) | |
